FDA approved gene therapies Flashcards

1
Q

why are gene therapeutic used?

A

for managing difficult to treat diseases- using nanoplexes and other carriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is gene therapy?

A

Human genetic disease= result of mutation or
deletion of gene (s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the aim of gene therapy?

A

To treat the cause rather than the
symptoms of the diseases= caused by single
gene mutation or deletion (e.g. Haemophilia,
Cystic fibrosis, Muscular dystrophy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when would gene therapy be used?

A

more than one
gene affected and no clear identification of the
position (s) of the defect (e.g. cancer,
Parkinson’s & Alzheimer’s disease )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how does gene therapy work?

A

Delivery of replacement or insertion gene
sequence into cell nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how may dna reach its site of action?

A

must pass a number of compartments
ie gene transfection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how is DNA and RNA made up?

A

DNA= deoxyribonucleic acid, carbohydrate unit
2-D-Deoxyribose
= represents genetic material
RNA= ribonucleic acid, carbohydrate unit 2-D-
Ribose
= essential for biosynthesis of proteins
=different types; here important mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the two principle ways of gene delivery to the cell nucleus?

A

viral and non-viral vectors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the risks associated with viral vectors?

A

safety risks
high immunogenicity after repeated admin
potential oncogenicity due to mutagenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what size must dna be in viral vectors?

A

small size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do non- viral vectors work?

A

coupling on polymers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what size molecules can be carried by non-viral vectors?

A

large DNA molecules can be carried

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the benefits of non-viral vectors?

A

can be produced in large quantities easily and inexpensively
significantly lower safety risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

do non-viral vectors have a low or high transfection efficiency?

A

low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the problematic properties of DNA?

A

*Highly charged polyelectrolyte
*Due to extra- and intracellular electrolyte concentrations stretched out
*Due to negative charge repulsive electrostatic interaction between DNA and negatively charged cell surface
*DNA size 800 nm to 10 μm
*Maximum possible size of DNA complex <1000 nm
*Carrier systems (DNA complexes)
*strong enough to protect DNA from blood plasma DNases
*weak enough to release DNA inside the target cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the problems associated with in vivo-gene delivery by cationic liposome dna complexes?

A

*Net positive charge
- when administered, for example, i.v. complexes will encounter negatively charged entities: serum proteins, lipoproteins and blood cells
- risk of flocculation and embolism
- positively charged particles are cleared from the circulation via reticuloendothelial system
*Pulmonary delivery
- encounter of lung surfactants
*Loss of positive charge leads to deterioration of transfection performance

17
Q

what is PEI?

A

Gene delivery using cationic polymers
Polyethylene imine (PEI)
*Gold standard of non viral vectors

18
Q

what are the properties of PEI?

A

*Can complex large DNA molecules
*Homogeneous spherical particles (~ 100 nm in size)
*Protection against nuclease degradation
*Fairly toxic

19
Q

what are obsticles to gene therapy?

A

immune reactions

20
Q

when is VEGR used?

A

For cardiovascular diseases
Gene therapy with VEGF has shown in
clinical trials to increase formation of new
vessels (angiogenesis) in ischaemic tissues
*Angiogenesis has therapeutic potential to
improve vascularisation in areas of
decreased blood flow caused by ischaemic
heart disease.

21
Q

what is chitosan?

A

Chitosans are biodegradable, linear amino
polysaccharides with a random distribution of b–
1,4–N–acetyl–D–glucosamine and D–
glucosamine.

22
Q

is chitosan safe?

A

They are derived from the biopolymer chitin and
are used in food preparations.
Hence, their use is safe.

23
Q

what are the properties of chitosan?

A

The polyplexes formed are stable, small and
toroidal in shape i.e. their appearance is similar
to a tyre or a hollow ring.

24
Q

how does chitosan protect DNA?

A

The DNA is entrapped in the inner cavity
and hence protected from degeneration by
DNase.

25
Q

how does chitosan stay stable and transfect target cells?

A

the amount of positively
charged monomer units in the polyplexes
must be greater than 65%.